Concentrate Potency and Product-Specific Risks
What the research says about high-potency cannabis and concentrates, including problem use, dependence and lung effects, with the limits of the evidence and no use advice.
Content last updated . This page has not been medically reviewed.
Quick answer
Cannabis concentrates hold more THC per gram than flower, and researchers ask whether that raises risk. The best systematic review found hints of a link with problem use but rated certainty "very low." This page gives facts, not use advice, and does not explain how to reach any level of intoxication. The owner of this site does not sell cannabis products.Evidence labels: insufficient evidence, mixed, evidence of harm (case-level), preclinical (lab only).
Cannabinoid concentration
Potency means the share of THC. A 2025 systematic review sorted studies into potency categories: 1 to 9%, 10 to 19%, 20 to 30%, kief/resin around 30 to 50%, and concentrates 60% or more. These are the reviewers' study categories, not a guarantee about any product. [1] Another review defined a concentrate as at least 50% cannabinoids by weight. [2] Percent THC on a label is a batch result at best; see percentages vs milligrams and THC vs THCA on a label. This site gives no typical percentage because composition varies and verified batch data is not available.What the evidence shows
| Question | Finding | Label |
|---|---|---|
| Problem cannabis use | Suggestive association with higher potency; 42 studies; certainty "very low" [1] | insufficient evidence, concern signal |
| Mental health, other outcomes | Less consistent, tending toward poorer outcomes [1] | mixed |
| Dependence (survey of 273 college students who used cannabis) | More frequent butane hash oil use linked to physical dependence after adjustment [3] | observational only |
| Dependence (410 people, measured THC) | Preference for high potency linked to slightly higher dependence risk; no link with measured THC concentration [4] | mixed |
| Subjective effects (574 people using both) | Flower rated more positive; negative effects of both small [5] | self-report |
| Therapeutic outcomes | Limited and mixed [1] | insufficient evidence |
Survey studies show association, not cause. People with more severe problems may seek stronger products.
Product-specific risks
- Inhaled concentrates. A case report described a 25-year-old with a long history of dabbing butane hash oil who developed acute lung injury mimicking pneumonia; it was treated with steroids and he was advised to stop. [6] A single case report cannot show how often this happens.
- Heating products. Laboratory work found that vaporizing or dabbing THC produced degradants including methacrolein, benzene and methyl vinyl ketone, with higher levels when terpenes were added; levels were lower than from smoking. [7]
- Additives and diluents. See vape liquids and cartridges for vitamin E acetate and pine rosin.
- Solvents. The extraction process may introduce harmful solvents such as naphtha, butane and petroleum ether, according to a clinical framework, which called concentrates generally not recommended for medical use. [8] See residual solvents in extracts.
- Age and conditions. The framework flagged people with significant comorbidities or older adults as possibly at greater risk. [8]
Special groups
Concentrates raise the same concerns as other THC products, with potency adding uncertainty: pregnancy (guide), adolescents (guide), psychosis or mania vulnerability (guide), and heart disease (guide). Also see dependence and withdrawal.When to get help
If someone is very confused, cannot breathe normally, has chest pain or a child swallowed a product, call 911 or US Poison Help at 1-800-222-1222. For distress or crisis in the US, call or text 988. See when to seek urgent help.Laws differ and change; not legal advice.
Frequently asked questions
Does higher THC mean more harm?
Evidence is suggestive for problem use but very low certainty. [1]
Do concentrates cause psychosis?
The review found less consistent results outside problem use, and the certainty was very low. [1] A 410-person study found no link between measured THC and psychosis-like symptoms. [4]
Are concentrates addictive?
One survey linked more frequent use of one type with greater physical dependence; it cannot show cause. [3]
Is a concentrate a medicine?
Not by itself; the clinical framework did not recommend them for medical cannabis use. [8]
Where do I read about edible delays?
References
- High-Potency Cannabis Use and Health: A Systematic Review of Observational and Experimental Studies. American Journal of Psychiatry. 2025. PubMed 40134269. Read 2026-10-22.
- Cannabis concentrate vaping chemistry. Frontiers in Toxicology. 2025. PubMed 40552084. Read 2026-10-22.
- Associations between butane hash oil use and cannabis-related problems. Drug and Alcohol Dependence. 2017. PubMed 28750253. Read 2026-10-22.
- High potency cannabis use, mental health symptoms and cannabis dependence: Triangulating the evidence. Addictive Behaviors. 2023. PubMed 37121087. Read 2026-10-22.
- A within-person comparison of the subjective effects of higher vs. lower-potency cannabis. Drug and Alcohol Dependence. 2020. PubMed 32858319. Read 2026-10-22.
- Cannabis Butane Hash Oil Dabbing Induced Lung Injury Mimicking Atypical Pneumonia. Cureus. 2020. PubMed 32211266 (case report). Read 2026-10-22.
- Aerosol Gas-Phase Components from Cannabis E-Cigarettes and Dabbing. ACS Omega. 2019. PubMed 31592479. Read 2026-10-22.
- MacCallum CA, Lo LA, Pistawka CA, Boivin M. A Clinical Framework for Evaluating Cannabis Product Quality and Safety. Cannabis and Cannabinoid Research. 2023;8(3):567-574. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.